Medical Weight Loss with GLP-1 Medications: A Cardiologist's Guide to What You Need to Know

As a cardiologist practicing in San Diego, I've watched the landscape of medical weight loss transform dramatically over the past few years. The introduction of GLP-1 receptor agonists for weight management has given us tools that were once the stuff of medical dreams. These medications represent the most significant advance in obesity treatment I've witnessed in my career, and I want to share with you exactly what they can and cannot do.

When patients ask me about these medications, I see a mixture of hope and skepticism in their eyes. They've often tried countless diets, exercise programs, and other weight loss approaches. Some have been disappointed before. My job is to give you the complete picture so you can make an informed decision about whether these medications might fit into your health journey.

The numbers are compelling. In clinical trials, patients using semaglutide (Wegovy) lost an average of 15% of their body weight over 68 weeks. Those using tirzepatide (Zepbound) saw even more dramatic results, with average weight losses of 18-20% over similar timeframes. For someone weighing 200 pounds, we're talking about 30-40 pounds of sustained weight loss. But these aren't magic bullets, and I want you to understand exactly how they work and what to expect.

How GLP-1 Medications Work

Let me explain the science in a way that makes sense. Your body produces a hormone called glucagon-like peptide-1, or GLP-1 for short. This hormone gets released from your intestines after you eat, and it does several important things. It tells your brain you're full, slows down how quickly food leaves your stomach, helps your pancreas release the right amount of insulin, and reduces the production of glucagon, another hormone that raises blood sugar.

Here's the problem: natural GLP-1 breaks down very quickly in your body, lasting only minutes. The medications we use are engineered versions that last much longer, typically a week for the injectable forms we prescribe for weight loss. Think of it as giving your body a more sustained and amplified version of its own appetite control system.

When you inject these medications, several things happen over the following days. Your appetite decreases significantly. Many of my patients tell me they simply stop thinking about food as much. The constant mental chatter about their next meal or snack quiets down. They feel satisfied with smaller portions and find that rich, high-calorie foods become less appealing.

The stomach effects are equally important. Food moves through your digestive system more slowly, which means you feel full longer after eating. This isn't just about willpower anymore. Your body's own regulatory systems are working more effectively to help you eat less without the constant struggle against hunger.

Understanding Your Results and What They Mean

When we start you on one of these medications, I want you to have realistic expectations about the timeline and pattern of weight loss. This isn't like the dramatic drops you might see in the first week of a very low-calorie diet. Instead, you'll typically lose 1-2 pounds per week, with some weeks showing more loss and others showing less or even temporary plateaus.

The most significant weight loss usually happens in the first 6-8 months of treatment. After that, the rate slows down, but many patients continue to lose small amounts over the following months. The key is that once you reach your new weight, the medication helps you maintain it, something that's historically been the biggest challenge in weight management.

I track several markers with my patients beyond just the scale. We look at waist circumference, blood pressure, blood sugar levels, and cholesterol profiles. Often, I see improvements in these cardiovascular risk factors even before dramatic weight changes occur. Your body composition changes too, with patients typically losing fat while preserving muscle mass, especially when combined with resistance exercise.

Not everyone responds the same way. About 15-20% of patients don't achieve significant weight loss even with maximum doses. We consider the medication effective if you lose at least 5% of your starting weight, but many patients lose much more. I've had patients lose 50, 60, even 80 pounds with these medications combined with lifestyle changes.

Who Should Consider GLP-1 Weight Loss Medications

The FDA has specific criteria for who can receive these medications for weight loss. You need to have a body mass index (BMI) of 30 or higher, which puts you in the obesity category. Alternatively, if your BMI is 27 or higher and you have at least one weight-related health condition like high blood pressure, type 2 diabetes, or high cholesterol, you may qualify.

But BMI alone doesn't tell the whole story. As a cardiologist, I'm particularly interested in patients who have cardiovascular risk factors that could improve with weight loss. If you have metabolic syndrome, prediabetes, sleep apnea, or a family history of heart disease, the benefits of significant weight loss extend far beyond appearance or even general health. We're talking about potentially life-changing improvements in your long-term cardiovascular health.

I also consider your previous weight loss attempts and your overall health picture. If you've tried multiple supervised diet and exercise programs without sustained success, these medications might provide the additional support your body needs. Some patients have hormonal or genetic factors that make traditional weight loss approaches insufficient, and GLP-1 medications can help level that playing field.

Age is another factor. While these medications are approved for adults, I find they can be particularly beneficial for patients in their 40s, 50s, and 60s who are dealing with metabolic changes that make weight management increasingly difficult. The cardiovascular benefits become even more important as we age.

How We Make Treatment Decisions Based on Your Response

Starting these medications requires a methodical approach. We don't jump to the full dose right away because that would likely cause intolerable side effects. Instead, we use what's called a titration schedule, gradually increasing your dose every few weeks to allow your body to adjust.

For semaglutide (Wegovy), we start at 0.25 mg once weekly for four weeks, then increase to 0.5 mg for four weeks, then 1.0 mg, then 1.7 mg, and finally 2.4 mg, which is the full therapeutic dose for weight loss. This process takes about 16-20 weeks, which I know sounds long, but it's necessary to minimize side effects and help your body adapt.

During this titration period, I'm monitoring several things. First, how well are you tolerating the medication? Are you experiencing nausea, vomiting, or other digestive issues that are interfering with your daily life? Second, are you seeing the expected appetite reduction and early weight loss? Third, are there any concerning side effects or changes in your lab work?

If you're not tolerating a particular dose well, we might stay at that level longer or even step back to the previous dose temporarily. There's no rush. The goal is to find the dose that gives you maximum benefit with manageable side effects. Some patients do very well on lower doses, while others need the full amount to see significant results.

Common Misconceptions About GLP-1 Weight Loss Medications

Let me address some of the myths and misconceptions I hear regularly in my practice. First, these are not appetite suppressants in the traditional sense. They're not stimulants like the diet pills of the past. They work by enhancing your body's natural appetite regulation systems, which is why the effects feel more natural and sustainable to most patients.

Second, these medications are not addictive. They don't create dependency or withdrawal symptoms. However, when you stop them, your appetite and weight will likely return toward where they were before treatment. This is why we usually plan for long-term use, just like we do with blood pressure or cholesterol medications.

Another misconception is that these medications will do all the work for you. While they significantly reduce appetite and make it easier to eat less, you still need to make good food choices and stay physically active. The medication gives you the tools to succeed, but you still need to use them effectively.

Some patients worry that losing weight with medication somehow "doesn't count" or isn't as good as losing weight through diet and exercise alone. This thinking is both unhelpful and inaccurate. If you have a medical condition that makes it extremely difficult to maintain a healthy weight, using an effective medical treatment is not cheating. It's appropriate medical care.

Understanding the Limitations

While these medications are highly effective for many patients, they have important limitations that I want you to understand. First, they don't work for everyone. As I mentioned, about 15-20% of patients don't achieve clinically significant weight loss even with optimal dosing and lifestyle changes.

Second, the weight loss, while substantial, may not be enough to reach your goal weight. If you're starting with a BMI of 40 and lose 20% of your body weight, you'll see tremendous health benefits, but you may still be in the overweight or even obese category. We have to balance realistic expectations with meaningful health improvements.

The side effects, while manageable for most patients, can be limiting for some. The gastrointestinal effects, nausea, vomiting, and diarrhea, usually improve over time but can persist in some patients. There are also rarer but more serious potential side effects, including pancreatitis and gallbladder problems, that we monitor for.

Cost and insurance coverage remain significant barriers for many patients. These medications are expensive, often $1,000 or more per month without insurance coverage. While many insurance plans are beginning to cover them, the criteria can be restrictive, and coverage isn't universal.

When NOT to Use GLP-1 Medications

There are specific situations where these medications are contraindicated, meaning they should not be used. If you have a personal or family history of medullary thyroid carcinoma, a rare type of thyroid cancer, or multiple endocrine neoplasia syndrome type 2 (MEN 2), these medications are not safe for you.

If you've had a severe allergic reaction to any GLP-1 medication or their components, you shouldn't use them. Pregnancy and breastfeeding are also contraindications, as we don't have adequate safety data in these situations.

I'm also cautious about prescribing these medications to patients with a history of severe gastroparesis (delayed stomach emptying) or those with active gallbladder disease. Patients with a history of pancreatitis need careful evaluation, as these medications might increase the risk of recurrence.

From a practical standpoint, if you're not prepared to make any lifestyle changes or if you have unrealistic expectations about what the medication can accomplish, it may not be the right time to start treatment. These medications work best as part of a comprehensive approach to weight management.

Managing Your Expectations

I want to be completely honest with you about what to expect when starting these medications. The first few weeks can be challenging as your body adjusts. Many patients experience nausea, especially in the first hour or two after injection. This usually improves over time, but it can be discouraging initially.

You may find that foods you previously enjoyed become unappetizing or even make you feel sick. Rich, fatty, or sweet foods often become particularly unappealing. While this helps with weight loss, it can require some adjustment in your social and eating patterns.

The appetite reduction can be dramatic. Some patients worry they're not eating enough or that they're developing an eating disorder. This is usually not the case, but it's important to focus on getting adequate nutrition even if you're eating much smaller quantities.

Weight loss may not be linear. You might lose several pounds one week and none the next. Some patients even experience temporary weight gain, especially in the first few weeks as their body adjusts. This is normal and doesn't mean the medication isn't working.

Energy levels can fluctuate as you adapt to eating less and as your body composition changes. Some patients feel more energetic as they lose weight and their health improves. Others feel fatigued initially as they adjust to lower calorie intake.

Integration with Your Overall Cardiovascular Care

As your cardiologist, I'm particularly interested in how weight loss with these medications fits into your overall cardiovascular health plan. The benefits extend far beyond the number on the scale. Weight loss with GLP-1 medications typically improves blood pressure, often allowing us to reduce or eliminate blood pressure medications.

Blood sugar control improves dramatically, even in patients without diabetes. This is important because improved insulin sensitivity reduces your risk of developing type 2 diabetes and cardiovascular disease. I often see improvements in hemoglobin A1c levels, a measure of long-term blood sugar control, even in non-diabetic patients.

Cholesterol profiles usually improve as well. LDL cholesterol (the "bad" cholesterol) often decreases, while HDL cholesterol (the "good" cholesterol) may increase. Triglyceride levels frequently improve significantly.

Sleep apnea, if present, often improves with weight loss, leading to better sleep quality and reduced cardiovascular stress. Inflammation markers in the blood, which are associated with increased cardiovascular risk, typically decrease as patients lose weight.

I coordinate the use of these medications with any other cardiovascular treatments you might need. If you're on blood pressure medications, we may need to adjust doses as you lose weight to prevent your blood pressure from dropping too low. If you have diabetes and are taking insulin or other diabetes medications, we'll need to monitor your blood sugars carefully to prevent hypoglycemia.

Future Directions and Emerging Options

The field of medical weight loss is evolving rapidly, and I'm excited about several developments on the horizon. Tirzepatide (Zepbound), which targets both GLP-1 and GIP receptors, is showing even more dramatic weight loss results than the original GLP-1 medications. Some patients in clinical trials lost 25% or more of their body weight.

Oral forms of these medications are in development, which could eliminate the need for weekly injections. There are also combination medications being studied that might provide even better results or fewer side effects.

Research is ongoing into using these medications for other conditions beyond diabetes and obesity. There's growing evidence that they may have direct cardiovascular benefits independent of weight loss, potentially reducing heart attack and stroke risk even in patients who don't lose significant weight.

We're also learning more about how to optimize the use of these medications. Studies are looking at the best ways to combine them with lifestyle interventions, other medications, and even surgical approaches for patients with severe obesity.

The cost of these medications is likely to decrease over time as more options become available and as generic versions are developed. This should improve access for patients who could benefit from treatment.

How to Approach This Decision

If you're considering GLP-1 medications for weight loss, I recommend starting with an honest assessment of your previous weight loss attempts and your current health status. Have you tried structured diet and exercise programs with professional guidance? What were the results, and what made it difficult to maintain any weight loss you achieved?

Consider your motivation and readiness for change. These medications make it easier to eat less, but you'll still need to make ongoing lifestyle changes to get the best results. Are you prepared to modify your eating habits, increase your physical activity, and attend regular follow-up appointments?

Think about your support system. Do you have family members or friends who will support your weight loss efforts? Are there people in your life who might sabotage your efforts, either intentionally or unintentionally?

Financial considerations are important. Check with your insurance company about coverage for weight loss medications. Even if they're not covered initially, the landscape is changing rapidly, and coverage may become available. Consider the cost in the context of your overall health spending and the potential savings from improved health outcomes.

Finally, find a healthcare provider who has experience with these medications and who will work with you as a partner in your weight loss journey. This isn't a "take this pill and come back in six months" kind of treatment. It requires ongoing monitoring, dose adjustments, and lifestyle counseling.

Making the Decision That's Right for You

The decision to start GLP-1 medications for weight loss is deeply personal and should be based on your individual health situation, goals, and circumstances. These medications represent a powerful tool, but they're not right for everyone, and they're not a substitute for healthy lifestyle choices.

If you have significant weight to lose and have struggled with traditional approaches, if you have weight-related health conditions that could improve with weight loss, and if you're prepared to make this a long-term commitment, these medications might be an excellent option for you.

The key is to approach this decision with realistic expectations and a complete understanding of both the benefits and limitations. Work with a healthcare provider who can guide you through the process, monitor your progress, and help you navigate any challenges that arise.

Remember that the goal isn't just weight loss. It's improved health, better quality of life, and reduced risk of serious medical conditions. If GLP-1 medications can help you achieve these goals safely and effectively, they may be worth considering as part of your overall health strategy.

The most important thing is that you make an informed decision based on accurate information and professional medical guidance. These medications have helped many of my patients achieve weight loss they never thought possible, but they're not magic. They're medical tools that work best when combined with commitment, lifestyle changes, and ongoing professional support.

References

1. Davies, Melanie J., Vanita R. Aroda, Billy S. Collins, et al. "Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)." Diabetes Care 45, no. 11 (2022): 2753-2786.

2. Elmaleh-Sachs, Alyssa, Judith L. Schwartz, Carolyn T. Bramante, et al. "Obesity Management in Adults: A Review." JAMA 330, no. 20 (2023): 2000-2015.

3. Moiz, Aliya, Kristian B. Filion, Hoda Toutounchi, et al. "Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss Among Adults Without Diabetes: A Systematic Review of Randomized Controlled Trials." Annals of Internal Medicine 178, no. 2 (2025): 199-217.

4. Grunvald, Eduardo, Raj Shah, Ruben Hernaez, et al. "AGA Clinical Practice Guideline on Pharmacological Interventions for Adults With Obesity." Gastroenterology 163, no. 5 (2022): 1198-1225.

5. Yanovski, Susan Z., and Jack A. Yanovski. "Approach to Obesity Treatment in Primary Care: A Review." JAMA Internal Medicine 184, no. 7 (2024): 818-829.

6. Liu, Yuxin, Bo Ruan, Haoyu Jiang, et al. "The Weight-Loss Effect of GLP-1RAs Glucagon-Like Peptide-1 Receptor Agonists in Non-Diabetic Individuals With Overweight or Obesity: A Systematic Review With Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Trials." The American Journal of Clinical Nutrition 118, no. 3 (2023): 614-626.

7. Gilbert, Oneida, Martha Gulati, Ty J. Gluckman, et al. "2025 Concise Clinical Guidance: An ACC Expert Consensus Statement on Medical Weight Management for Optimization of Cardiovascular Health: A Report of the American College of Cardiology Solution Set Oversight Committee." Journal of the American College of Cardiology (2025): S0735-1097(25)06504-0.

8. Jastreboff, Ania M., Louis J. Aronne, Nadia N. Ahmad, et al. "Tirzepatide Once Weekly for the Treatment of Obesity." New England Journal of Medicine 387, no. 3 (2022): 205-216.

9. Wilding, John P.H., Rachel L. Batterham, Salvatore Calanna, et al. "Once-Weekly Semaglutide in Adults with Overweight or Obesity." New England Journal of Medicine 384, no. 11 (2021): 989-1002.

10. Pi-Sunyer, Xavier, Astrup Arne, Ken Fujioka, et al. "A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management." New England Journal of Medicine 373, no. 1 (2015): 11-22.

Published on damianrasch.com The above information was composed by Dr. Damian Rasch, drawing on individual insight and bolstered by digital research and writing assistance. The information is for educational purposes only and does not constitute medical advice.